NCT04366050View on ClinicalTrials.gov

Ramipril for the Treatment of COVID-19

PHASE2CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

May 11, 2020

Primary Completion Date

May 12, 2021

Study Completion Date

May 12, 2021

Conditions

COVID-19

Interventions

DRUG

Ramipril 2.5 MG Oral Capsule

Include description or ramipril from protocol

DRUG

Placebo oral capsule

Placebo

Trial Locations (1)

92093

University of California, San Diego, La Jolla

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

University of California, San Diego

OTHER